The core of the project offers a highly-sensitive “lab-on-a-chip” device built using a nanoimprinting technology to enable much faster production at minimal costs. An optical reader will also be developed to enable user-friendly readout and interpretation of results. The resulting tool can easily be adapted to a wider infectious disease market for other pleomorphic bacteria such as chronic Lyme disease and bacteria involved in other serious diseases.
